We are a technology platform company that can overcome the limitations to greater use of peptides in health and agriculture. In addition to development of our proprietary drug candidate to treat cachexia, we identify alliance partners whose product candidate can be enabled or enhanced by our technology. We transform their product candidate for a fee and receive license revenue when successful products use our technology.